The Alkaline Non-Structural Protein–Ferritin–TRPV1 Axis: A Unified Chemical Model for Fever, Viral Latency, and HIV Associated CD4 Exhaustion

Abstract

Current fever models attribute hypothalamic set‑point elevation to prostaglandin E2, yet they fail to explain the incubation period, ferroptosis, or the perplexing CD4 depletion in HIV patients under suppressive antiretroviral therapy. We propose a fundamentally different framework: many viral non‑structural proteins (NSPs) are highly basic (high pI). Upon release into the blood, they act as chemical “proton scavengers” that attack the ferritin iron core, specifically disrupting the hydroxyl‑bridged Fe³⁺ lattice. This triggers a burst of Fe²⁺, which fuels the Fenton reaction, generating massive reactive oxygen species (ROS). ROS activate peripheral TRPV1‑positive sensory nerves (facial and vagal), transmitting signals to the preoptic anterior hypothalamus – a process we term “thermal allergy.” In this model, the incubation period represents the time needed for NSP accumulation to exceed blood buffering capacity; ferroptosis occurs when continuous hyperthermia (≥39 °C) overwhelms the GPX4‑glutathione system. Extending this to HIV, we hypothesise that chronic, low‑grade release of basic NSPs (Nef, Tat) causes persistent allergic‑like oxidative stress in lymphoid tissues, leading to functional CD4 exhaustion rather than direct viral lysis. This provides a mechanistic explanation for immune failure despite viral suppression. Finally, we propose a therapeutic strategy based on targeted hydrochloride salts – organic acids that neutralise basic NSPs – combined with mast‑cell stabilisers to block the allergic signal, offering a paradigm shift from antiviral to “chemical detoxification” therapy.